Your browser doesn't support javascript.
loading
SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4+ T Lymphocytes.
Lacher, Markus D; Bauer, Gerhard; Fury, Brian; Graeve, Sanne; Fledderman, Emily L; Petrie, Tye D; Coleal-Bergum, Dane P; Hackett, Tia; Perotti, Nicholas H; Kong, Ying Y; Kwok, William W; Wagner, Joseph P; Wiseman, Charles L; Williams, William V.
Afiliación
  • Lacher MD; BriaCell Therapeutics Corp., Berkeley, CA, United States.
  • Bauer G; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States.
  • Fury B; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States.
  • Graeve S; BriaCell Therapeutics Corp., Berkeley, CA, United States.
  • Fledderman EL; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States.
  • Petrie TD; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States.
  • Coleal-Bergum DP; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States.
  • Hackett T; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States.
  • Perotti NH; GMP Facility, Institute for Regenerative Cures, University of California, Davis (UCD), Sacramento, CA, United States.
  • Kong YY; Benaroya Research Institute at Virginia Mason, Seattle, WA, United States.
  • Kwok WW; Benaroya Research Institute at Virginia Mason, Seattle, WA, United States.
  • Wagner JP; BriaCell Therapeutics Corp., Berkeley, CA, United States.
  • Wiseman CL; BriaCell Therapeutics Corp., Berkeley, CA, United States.
  • Williams WV; BriaCell Therapeutics Corp., Berkeley, CA, United States.
Front Immunol ; 9: 776, 2018.
Article en En | MEDLINE | ID: mdl-29867922
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Linfocitos T CD4-Positivos / Vacunas contra el Cáncer / Línea Celular Tumoral / Inmunoterapia Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Front Immunol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Linfocitos T CD4-Positivos / Vacunas contra el Cáncer / Línea Celular Tumoral / Inmunoterapia Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Front Immunol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza